Address: 301 A-Leela Business Park,M.V. Road, Andheri
Tel: +91 22 5677 4242
Quintiles Transnational is a pharmaceutical services company offering clinical, commercial, consulting and capital services. The Quintiles network consists of more than 20,000 employees in 60 countries.
Quintiles manages clinical trials on behalf of pharmaceutical customers, and provides the following services:
Management of clinical trials, data, projects and providing laboratory services
Providing customers with sales force, product and brand solutions.
Providing data-driven recommendations to help customers achieve success.
Creating strategic partnerships through financing and operational solutions.
Quintiles India is located amidst a rapidly growing local pharmaceutical market. With five offices spread across the country, we help clients take advantage of a well-established corporate infrastructure, government policies favoring R&D, growth in the health insurance sector, and tertiary care and teaching hospitals available for trials.
Other advantages: Quintiles India has solid relationships with leading medical centers and experienced English-speaking investigators. All studies are conducted to FDA and ICH GCP standards. Urban India’s literate population provides fast, efficient access to broad population groups with common and special disease profiles, allowing for rapid patient recruitment and faster study start-ups.
Quintiles helped develop or commercialize all of 2009’s top 50 best selling drugs or compounds and nearly 90% of all breakthrough products released on the market between 1996 and 2008.
Key Services in India:
Access to patients
Central laboratory services
Clinical monitoring and site management
Data management offering a functional service provider (FSP) business model
ECG monitoring services
Access through Our India Team to Quintiles Worldwide:
A strong advocate for women’s health and the first managing director of Roche Diagnostics India to be under 40…
With his over 25 years’ experience in running growing businesses and establishing start-ups, Ranjit Madan, CEO of…
Dilip G Shah, secretary-general of the Indian Pharmaceutical Alliance (IPA) and member of the Expert Review…
A passionate advocate for reverse mentoring, Abbott India Limited’s managing director, Venu Ambati, discusses the…
India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the…
As a young pathbreaking transformer in the Indian pharmaceutical landscape, Yogesh Agrawal, managing director of…
Sanjay Bhutani, managing director of Bausch & Lomb India and SAARC operations, gives his insights into the…
At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based…
Bhupendra Singh, chairman of the Indian National Pharmaceutical Pricing Authority (NPPA), provides an overview of…
Sir Dr. Huz, CEO and trustee of the Wockhardt Foundation and executive director of Wockhardt, discusses the role…
The secretary-general of the Indian Drug Manufacturers Association (IDMA) gives his insight into the current state…